Brian Chi is a Managing Director in the Private Equity Group and is based in Hong Kong.
Since joining Blackstone, Mr. Chi has been involved in Blackstone’s investment in Xinrong Medical and HEC Pharma. He currently serves on the Board of Directors of Xinrong Medical. Before joining Blackstone, Mr. Chi was a Vice President at Morgan Stanley Private Equity Asia where he focused on private equity investments in China. Before joining Morgan Stanley, Mr. Chi worked in the Mergers & Acquisitions Group at Citi Investment Banking Division in New York.
Mr. Chi received a BA in Economics and Math from Brandeis University, where he graduated summa cum laude, and an MBA from Harvard Business School.